JP2011516477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516477A5 JP2011516477A5 JP2011502992A JP2011502992A JP2011516477A5 JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5 JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- dry eye
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 4
- 206010013774 Dry eye Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 102000015728 Mucins Human genes 0.000 claims 2
- 108010063954 Mucins Proteins 0.000 claims 2
- 150000001923 cyclic compounds Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000816 peptidomimetic Substances 0.000 claims 2
- 230000028327 secretion Effects 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12303608P | 2008-04-04 | 2008-04-04 | |
| US61/123,036 | 2008-04-04 | ||
| US20887309P | 2009-02-27 | 2009-02-27 | |
| US61/208,873 | 2009-02-27 | ||
| PCT/US2009/002121 WO2009123761A1 (en) | 2008-04-04 | 2009-04-03 | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025563A Division JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011516477A JP2011516477A (ja) | 2011-05-26 |
| JP2011516477A5 true JP2011516477A5 (enExample) | 2012-05-24 |
| JP5480242B2 JP5480242B2 (ja) | 2014-04-23 |
Family
ID=40897413
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011502992A Active JP5480242B2 (ja) | 2008-04-04 | 2009-04-03 | ドライアイ治療用βターンペプチド模倣環式化合物 |
| JP2014025563A Active JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025563A Active JP5870348B2 (ja) | 2008-04-04 | 2014-02-13 | ドライアイ治療用βターンペプチド模倣環式化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US8293713B2 (enExample) |
| EP (1) | EP2271337B1 (enExample) |
| JP (2) | JP5480242B2 (enExample) |
| KR (1) | KR101565185B1 (enExample) |
| CN (1) | CN102046166B (enExample) |
| AU (1) | AU2009232352B2 (enExample) |
| CA (1) | CA2720141C (enExample) |
| ES (1) | ES2521515T3 (enExample) |
| WO (1) | WO2009123761A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293713B2 (en) | 2008-04-04 | 2012-10-23 | Mimetogen Pharmaceuticals, Inc. | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| US9115179B2 (en) * | 2012-06-22 | 2015-08-25 | Mimetogen Pharmaceuticals Inc. | Synthesis of beta-turn peptidomimetic cyclic compounds |
| KR20150004652A (ko) | 2013-07-03 | 2015-01-13 | 삼성디스플레이 주식회사 | 표시 패널, 이를 포함하는 표시 장치 및 이를 이용하는 영상 표시 방법 |
| JP6267003B2 (ja) * | 2014-02-27 | 2018-01-24 | 参天製薬株式会社 | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 |
| WO2016115050A1 (en) | 2015-01-12 | 2016-07-21 | Lagunita Llc | Micro-droplet delivery device and methods |
| CN107530509A (zh) | 2015-04-10 | 2018-01-02 | 科达莱昂治疗公司 | 具有可替换安瓿的压电分配器 |
| JP6801835B2 (ja) | 2015-07-09 | 2020-12-16 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | β−ターンペプチド模倣環状塩の液相合成及び結晶化 |
| KR101718733B1 (ko) | 2015-08-21 | 2017-03-22 | 국제약품 주식회사 | 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제 |
| JP2019507193A (ja) | 2016-03-04 | 2019-03-14 | ジェームズ・エム・ライナーソン | 細菌のバイオフィルム形成を阻止又は妨害することによって眼障害を治療する方法 |
| KR102866401B1 (ko) | 2017-01-20 | 2025-10-01 | 보슈 롬 아일랜드 리미티드 | 압전 유체 분배기 |
| CA3083219A1 (en) | 2017-12-08 | 2019-06-13 | Reynaldo Quintana | Fluid delivery alignment system |
| CN110092799B (zh) * | 2018-01-29 | 2021-11-12 | 广州丹康医药生物有限公司 | 一种环状化合物、其制备方法和应用 |
| US20190314196A1 (en) | 2018-04-12 | 2019-10-17 | Kedalion Therapeutics, Inc. | Topical Ocular Delivery Methods and Devices for Use in the Same |
| US12350194B1 (en) | 2018-04-12 | 2025-07-08 | Bausch + Lomb Ireland Limited | Topical ocular delivery of fluids with controlled mass dosing and wireless communication |
| AU2019297326B2 (en) | 2018-07-03 | 2025-01-09 | Bausch + Lomb Ireland Limited | Topical ocular delivery devices and methods for using the same |
| US12097145B2 (en) | 2019-03-06 | 2024-09-24 | Bausch + Lomb Ireland Limited | Vented multi-dose ocular fluid delivery system |
| US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
| US12090087B2 (en) | 2020-04-17 | 2024-09-17 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir |
| IL297215A (en) | 2020-04-17 | 2022-12-01 | Kedallon Therapeutics Inc | A hydrodynamically activated preservative free distribution system |
| US12290472B2 (en) | 2020-04-17 | 2025-05-06 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| US11938057B2 (en) | 2020-04-17 | 2024-03-26 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| IL308909A (en) * | 2021-06-02 | 2024-01-01 | The Texas A& M Univ System | Selective small molecule agonists and partial agonists of TRK receptors |
| WO2023069255A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| CA3234071A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917217D0 (en) * | 1989-07-27 | 1989-09-13 | Smith & Nephew | Ophthalmic compositions |
| US5545617A (en) | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| CA2316015A1 (en) * | 1997-12-22 | 1999-07-01 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
| JP2001064198A (ja) | 1999-08-24 | 2001-03-13 | Teika Seiyaku Kk | 角膜疾患治療剤 |
| EP1265605B1 (en) | 2000-01-18 | 2006-09-27 | McGILL UNIVERSITY | Pharmaceutical compositions comprising beta-turn peptidomimetic cyclic compounds |
| ATE423135T1 (de) | 2005-06-13 | 2009-03-15 | Primm Srl | Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten |
| EP1921087A1 (en) | 2006-11-10 | 2008-05-14 | Primm S.R.L. | Process for the preparation of cyclic peptides |
| CA2671613C (en) * | 2006-12-05 | 2018-07-03 | The Royal Institution For The Advancement Of Learning/Mcgill University | Methods of use of trk receptor modulators |
| US8293713B2 (en) | 2008-04-04 | 2012-10-23 | Mimetogen Pharmaceuticals, Inc. | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| ES2512717T3 (es) * | 2009-02-27 | 2014-10-24 | Mimetogen Pharmaceuticals Inc. | Compuestos cíclicos peptidomiméticos para el tratamiento de la retinitis pigmentosa |
| US9115179B2 (en) * | 2012-06-22 | 2015-08-25 | Mimetogen Pharmaceuticals Inc. | Synthesis of beta-turn peptidomimetic cyclic compounds |
-
2009
- 2009-04-03 US US12/935,217 patent/US8293713B2/en active Active
- 2009-04-03 AU AU2009232352A patent/AU2009232352B2/en active Active
- 2009-04-03 KR KR1020107024714A patent/KR101565185B1/ko active Active
- 2009-04-03 WO PCT/US2009/002121 patent/WO2009123761A1/en not_active Ceased
- 2009-04-03 CN CN2009801190689A patent/CN102046166B/zh active Active
- 2009-04-03 JP JP2011502992A patent/JP5480242B2/ja active Active
- 2009-04-03 EP EP09726969.0A patent/EP2271337B1/en active Active
- 2009-04-03 CA CA2720141A patent/CA2720141C/en active Active
- 2009-04-03 ES ES09726969.0T patent/ES2521515T3/es active Active
-
2012
- 2012-08-31 US US13/601,258 patent/US8748391B2/en active Active
-
2014
- 2014-02-13 JP JP2014025563A patent/JP5870348B2/ja active Active
- 2014-05-29 US US14/290,845 patent/US9156882B2/en active Active
-
2015
- 2015-09-18 US US14/858,874 patent/US9707267B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516477A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2013520405A5 (enExample) | ||
| FI3811943T3 (fi) | Yhdiste käytettäväksi silmäsairauksien hoidossa | |
| JP2013518107A5 (enExample) | ||
| JP2014530220A5 (enExample) | ||
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| JP2015501783A5 (enExample) | ||
| EA201490774A1 (ru) | Новые производные оксазина и их применение при лечении заболевания | |
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| JP2012255026A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| RU2014120792A (ru) | Способ лечения стромальных опухолей желудочно-кишечного тракта | |
| JP2013519675A5 (enExample) | ||
| JP2013534527A5 (enExample) | ||
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| MX339614B (es) | Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2. | |
| RU2017139870A (ru) | Новые агонисты npr-b | |
| RU2017114352A (ru) | АНТАГОНИСТЫ ИНТЕГРИНА ανβ6 | |
| JP2015516419A5 (enExample) | ||
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| BR112014009165A8 (pt) | sal e uso médico | |
| EA201270653A1 (ru) | Антагонист dpи его применение | |
| JP2013523739A5 (enExample) | ||
| JP2012525422A5 (enExample) |